[Effect of piascledine treatment of scleroderma].
D000293:Adolescent; D000328:Adult; D000368:Aged; D002214:Capsules; D002648:Child; D004338:Drug Combinations; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010840:Phytosterols / Q000008:administration & dosage / Q000627:therapeutic use*; D010936:Plant Extracts / Q000008:administration & dosage / Q000627:therapeutic use; D012594:Scleroderma, Localized / Q000188:drug therapy*; D012595:Scleroderma, Systemic / Q000188:drug therapy*; D014810:Vitamin E / Q000008:administration & dosage / Q000627:therapeutic use*
D002214:Capsules; D004338:Drug Combinations; D010840:Phytosterols; D010936:Plant Extracts; D014810:Vitamin E
Ocena działania preparatu piascledine w leczeniu twardziny